Try the questions in the test above first, then open each one here to see the correct answer and why every other option is wrong.
01A 34-year-old woman has hemoglobin 5.8 g/dL, a red cell count of 1.8 × 10^12/L and a reticulocyte percentage of 0.9%. The leukocyte and platelet counts are also reduced. After calculating the absolute reticulocyte count, what is the best interpretation of the marrow response?
Practice question Unit: Hematology
AIncreased erythropoietic output from ongoing hemolysis
Hemolysis would produce an absolute count above roughly 80,000/µL; a count near 16,000/µL shows the marrow is not responding to the anemia.
BNormal marrow with a dilutional fall in hemoglobin
Dilution would not explain a severely low absolute reticulocyte count combined with reduced leukocytes and platelets, which indicates a production problem.
CSeverely impaired erythropoiesis, as in marrow failure ✓ Correct answer
The absolute count is about 16,000/µL, below roughly 20,000/µL, so severe anemia with this low output points to failed production, as in aplastic anemia.
DAppropriate response to blood loss with a normal marrow
Bleeding with a healthy marrow would raise the absolute reticulocyte count above roughly 80,000/µL; this count is far lower, and other lineages are low too.
Reference: How to Interpret the Complete Blood Count in Daily Practice: A Practical Framework for Clinical Decision-making (JMA Journal, 2026), section "Step 2: Evaluate the RBC lineage"
Ask a friend
02A sample gives Hb 9.0 g/dL, RBC 1.9 × 10^12/L, Hct 20%, MCV 105 fL and MCHC 45 g/dL. The film shows irregular clumps of red cells. What is the best first step before reporting?
Practice question Unit: Hematology
AVortex the sample for 1 to 2 minutes and rerun
Vortexing is used to disaggregate platelet or white cell clumps, whereas cold agglutinin artefact is corrected by prewarming the sample to 37 °C.
BReport the values and start an iron-deficiency work-up
An MCHC of 45 g/dL is physiologically implausible, so reporting it as real and chasing iron deficiency would mislead the clinician.
CPrewarm the sample at 37 °C and rerun ✓ Correct answer
Cold agglutinins cause falsely high MCHC and low RBC and Hct, and prewarming the sample restores reliable red cell parameters.
DCollect a new sample in citrate and correct for dilution
Citrated collection with a dilution correction is used for platelet or white cell clumping, and it would not correct red cell agglutination at room temperature.
Reference: Purpose and Criteria for Blood Smear Scan, Blood Smear Examination, and Blood Smear Review (Annals of Laboratory Medicine, 2013), section "2. Blood Smear Examination (BSE)"
Ask a friend
03Two patients have microcytic anemia. Patient 1 has MCV 66 fL, RDW 20% and a mildly reduced RBC count. Patient 2 has MCV 68 fL, RDW 12.5% and a relatively preserved RBC count. Which pairing of the leading interpretations is most appropriate?
Practice question Unit: Hematology
APatient 1 shows uniform microcytosis typical of thalassemia trait; patient 2 shows heterogeneous microcytosis typical of iron deficiency
This reverses the pattern. Thalassemia trait gives uniform microcytosis with normal RDW, whereas iron deficiency produces a mixed population of cells with a high RDW.
BPatient 1 shows heterogeneous microcytosis suggesting iron deficiency; patient 2 shows uniform microcytosis suggesting thalassemia trait ✓ Correct answer
Low MCV with high RDW means heterogeneous microcytosis, typical of iron deficiency, while low MCV with normal RDW and preserved RBC count suggests thalassemia trait.
CBoth patients have thalassemia trait because the RBC count is not markedly reduced in either case
Patient 1 has a markedly raised RDW, which argues for a mixed cell population rather than thalassemia trait, so this pairing ignores size variability.
DBoth patients have iron deficiency anemia because each MCV is below the lower reference limit of 80 fL
A low MCV alone cannot assign the cause. RDW separates a mixed population from a uniform one, so patient 2 does not fit iron deficiency.
Reference: How to Interpret the Complete Blood Count in Daily Practice: A Practical Framework for Clinical Decision-making (JMA Journal, 2026), section "Step 2: Evaluate the RBC lineage"
Ask a friend
04A 6-year-old boy is admitted with jaundice and dark urine two days after starting a sulfonamide. Hb is 7.1 g/dL, reticulocytes are raised and haptoglobin is low. A quantitative G6PD assay run on admission is within the reference range, and a maternal uncle has G6PD deficiency. How should this result be handled?
Practice question Unit: Hematology
AAccept the result and exclude G6PD deficiency, since the measured enzyme activity is within the reference range
During an acute episode the most deficient cells lyse first, leaving younger cells with better activity, so a normal value can be falsely reassuring.
BRepeat the assay at once on a fresh sample, since the first draw is likely to have been diluted by the acute hemolysis
A repeat on the same day samples the same surviving, relatively enzyme-rich cell population and would be expected to give the same falsely normal answer.
CRepeat the assay several months later, once a new population of red cells has entered the circulation ✓ Correct answer
After several months the surviving enzyme-rich cells are replaced by a full new red cell population, so activity reflects the true phenotype.
DReplace the enzyme assay with a direct antiglobulin test, since the normal activity result points to immune hemolysis
Immune hemolysis is investigated with the antiglobulin test, but a normal acute-phase enzyme value neither rules out G6PD deficiency nor points to another cause.
Reference: Educational Case: Glucose-6-phosphate dehydrogenase (G6PD) deficiency anemia (Academic Pathology, 2026), section "When should this patient receive testing for G6PD deficiency?"
Ask a friend
05An analyzer reports a WBC count of 2.8 × 10^9/L. The manual differential on the smear shows 20% segmented neutrophils, 6% band neutrophils, 62% lymphocytes, 10% monocytes and 2% eosinophils. What is the absolute neutrophil count?
Practice question Unit: Hematology
A0.17 × 10^9/L
This value counts only the band neutrophils, so it leaves out the segmented neutrophils that are also part of the ANC.
B0.56 × 10^9/L
This value counts only the segmented neutrophils and ignores the 6% bands, which must be added to the segmented percentage.
C0.73 × 10^9/L ✓ Correct answer
The ANC is the WBC count times the combined percentage of segmented and band neutrophils: 2.8 × 0.26 gives 0.73 × 10^9/L.
D7.28 × 10^9/L
This result comes from a decimal error, multiplying by 2.6 instead of 0.26, and exceeds the total WBC count of 2.8.
Reference: How to Interpret and Pursue an Abnormal Complete Blood Cell Count in Adults (Mayo Clinic Proceedings, 2011), section "Neutropenia"
Ask a friend
06A patient with APL has INR 1.4, fibrinogen 70 mg/dL and platelets 62,000/µL. Which parameter is below the usual supportive target and needs product replacement?
Practice question Unit: Hematology
APlatelet count, which should be kept above 30,000/µL
Platelets of 62,000/µL already exceed the 30,000/µL target, so transfusion is not required for this result.
BINR, which should be kept below 1.5–2.0
An INR of 1.4 is already below the 1.5–2.0 limit, so plasma is not needed for this value.
CPlatelet count, which should be kept above 100,000/µL
The supportive platelet target in APL is above 30,000/µL, not 100,000/µL, so 62,000/µL needs no transfusion.
DFibrinogen, which should be kept above 100 mg/dL ✓ Correct answer
The fibrinogen target is above 100 mg/dL, so a value of 70 mg/dL needs correction with blood products.
Reference: Acute promyelocytic leukemia current treatment algorithms (Blood Cancer Journal, 2021), section "Approach to suspected APL"
Ask a friend
07A laboratory obtains a forward group of B (anti-B reactive, anti-A negative). The reverse group shows the expected agglutination of A1 cells, but B cells also agglutinate at room temperature, and the autologous control is positive. Which step best resolves the discrepancy?
Practice question Unit: Blood Bank
AReport group AB, because both types of reverse cells have now been agglutinated
A group AB patient has both antigens on the red cells. The forward group here shows no A antigen, so reverse reactions cannot define AB.
BRepeat the forward group with enzyme-treated cells to strengthen the missing anti-A reaction
The forward group is not the problem, and enzymes do not create A antigen. Anti-A is correctly negative, so this repeat explains nothing.
CRepeat the reverse group at 37 °C and investigate a cold-active auto- or alloantibody ✓ Correct answer
Extra reverse-group reactions point to antibodies active below 37 °C. Repeating at 37 °C separates them from true ABO antibodies.
DReport group B and disregard the extra B-cell reaction as a non-specific room-temperature effect
An unexplained extra reverse-group reaction may come from cold-active allo- or autoantibodies, which must be investigated before any ABO group is assigned.
Reference: JPAC Guidelines for the Blood Transfusion and Tissue Transplantation Services in the UK (Red Book), current web edition, chapter 13 patient testing, section "13.3.1: Resolution of anomalous grouping"
Ask a friend
08A European patient has anaphylaxis within minutes of receiving a plasma-containing blood product, and red cell compatibility testing is normal. Which first-line work-up best explains the reaction?
Practice question Unit: Immunology and Serology
ADirect antiglobulin test on the pre-transfusion red cells
A DAT detects red cell sensitisation and does not address an immediate allergic reaction to a plasma protein.
BPlasma IgA level plus IgG and IgE antibodies to IgA ✓ Correct answer
Plasma protein levels and IgG and IgE antibodies to IgA are examined first when plasma proteins such as IgA are suspected allergens.
CCulture of the blood component for bacteria
Bacterial contamination can cause fever and shock, but the clue here is anaphylaxis within minutes with normal red cell testing.
DHaptoglobin genotyping of the recipient
The haptoglobin deletion allele is found in East Asians but has not been detected in Europeans, so it is unlikely here.
Reference: Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment 2013, section "Laboratory tests"
Ask a friend
09A haematology laboratory sets its allowable total error for haemoglobin at 10%. On a two-level control, its analyser shows an average bias of 2% and a coefficient of variation of 2.5%. What is the sigma metric and how is this performance graded?
Practice question Unit: Laboratory Operations
A2.2 sigma, poor grade
Dividing allowable error by the sum of bias and CV mixes up the terms and does not reflect the margin left after bias.
B3.2 sigma, marginal grade ✓ Correct answer
Sigma is allowable error minus bias, divided by CV: (10 − 2) / 2.5 = 3.2, which lies in the marginal grade.
C4.0 sigma, good grade
Dividing allowable error by CV alone ignores the bias already consuming part of the error budget, so the margin is overstated.
D4.8 sigma, good grade
Adding bias to allowable error instead of subtracting it inflates the numerator and wrongly places the assay in the good grade.
Reference: Practical application of Westgard Sigma rules with run size in analytical biochemistry processes in clinical settings 2020, section "Results"
Ask a friend
10A pre-operative patient types as group O D-positive, but her record from six months earlier shows group A D-positive. She has had no stem cell transplant, and a repeat sample now types as group A D-positive. What is the best conclusion and follow-up?
Practice question Unit: Patient Safety and Professionalism
AThe historical record was entered wrongly, so the new group should replace it once the surgery is completed
The repeat sample confirmed the older result, so replacing it would remove the very safeguard that exposed the problem.
BThe first tube came from another patient, so the collection area is alerted ✓ Correct answer
A direct identifier swap could put another patient's blood under this name, so the collection area is alerted and the other patient traced.
CThe first grouping reagents were faulty, so the reagent supply needs investigating before testing resumes
Reagent faults would not explain why a second sample matched history; the pattern points to a wrong-patient tube, not a testing failure.
DHer group changed after the earlier record was made, so both results can be kept on file as valid
Blood group does not alter without a stem cell transplant, and the repeat sample excludes a true change, leaving a wrong-patient tube as the explanation.
Reference: Educational Case: Wrong Blood in Tube (Academic Pathology, 2017), section "What Are Your Conclusions?"
Ask a friend